Argent BioPharma Limited

    Argent BioPharma Limited

    LLSE:RGT
    - -
    GBp
    - -
    - -
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    0.12
    0.26
    0.54
    1.5
    1.55
    1.84
    1.15
    - -
    Basic EPS, GAAP
    -11.25
    -11.83
    -33.37
    -13.43
    -10.2
    -8.43
    -7.33
    -1.91
    -14.01
    -8.33
    -7.93
    -7.08
    - -
    Free Cash Flow per Basic Share
    -14.68
    -8.4
    -2.96
    -2.18
    -5.54
    -5.99
    -0.41
    -0.3
    -0.7
    -1.75
    -1.05
    -0.06
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    30.46
    118.8
    25.11
    3.6
    17.73
    13.22
    9.25
    6.34
    -1.43
    3.42
    -0.43
    -5.26
    - -
    Tangible Book Value per Share
    30.46
    122.59
    28.44
    6.81
    7.7
    9.02
    4.98
    4.77
    2.24
    3.56
    0.79
    -2.73
    - -
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    1
    2
    3
    3
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    2
    3
    5
    3
    1
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    -6,087.36
    -2,446.32
    -1,377.42
    -567.76
    -407.37
    -301.38
    -460.46
    -2,049.4
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    Net Income, GAAP
    - -
    -1
    -5
    -4
    -6
    -8
    -8
    -2
    -19
    -16
    -20
    -21
    -18
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    -6,773.31
    -2,778.31
    -351.91
    -931.29
    -535.62
    -430
    -614.71
    -1,967.34
    Working Capital
    - -
    - -
    - -
    - -
    4
    8
    4
    2
    - -
    3
    -1
    -11
    -9
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    2
    2
    2
    - -
    1
    Total Equity
    1
    8
    5
    2
    12
    16
    13
    11
    3
    14
    5
    -8
    -6
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    -36.01
    -18.07
    -91.12
    -150.85
    -105.05
    -69.38
    -71.14
    -25.55
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    AUD

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    AUD

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    AUD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    38.16%
    -13.92%
    -27.48%
    Free Cash Flow
    70.49%
    54.65%
    -26.2%
    Net Income, GAAP
    73%
    147.03%
    -15.81%
    Sales/Revenue/Turnover
    - -
    43.39%
    -73.7%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    AUD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    5
    2023
    - -
    - -
    - -
    - -
    3
    2024
    - -
    - -
    - -
    - -
    1

    Quarterly Earnings Per Share

    AUD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    -7.93
    2023
    - -
    - -
    - -
    - -
    -7.08
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    AUD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business